We are live on ! Find out more
EAM

EULAV Asset Management Portfolio holdings

AUM $3.13B
1-Year Est. Return 23.04%
This Fund
S&P 500
This Quarter Est. Return
+9.43%
1 Year Est. Return
+23.04%
3 Year Est. Return
+90.7%
5 Year Est. Return
+115.08%
10 Year Est. Return
+583.23%
AUM
$2.33B
AUM Growth
+$70.1M
Cap. Flow
-$89.7M
Cap. Flow %
-3.85%
Top 10 Hldgs %
23.05%
Holding
203
New
5
Increased
30
Reduced
65
Closed
11

Top Buys

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$12.8M
2
IQV icon
IQVIA
IQV
+$8.32M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$7.79M
4
POOL icon
Pool Corp
POOL
+$7.16M
5
DVN icon
Devon Energy
DVN
+$6.82M

Top Sells

Rank Stock Value
1
DHR icon
Danaher
DHR
+$29.3M
2
ACGL icon
Arch Capital
ACGL
+$24.2M
3
NEE icon
NextEra Energy
NEE
+$11.7M
4
FISV
Fiserv Inc
FISV
+$8.96M
5
ECL icon
Ecolab
ECL
+$6.6M

Sector Composition

Rank Sector Weight
1 Technology 33.52%
2 Industrials 18.51%
3 Financials 15.9%
4 Healthcare 15.48%
5 Consumer Discretionary 6.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WWD icon
76
Woodward
WWD
$21.3B
$8.98M 0.39%
93,000
– –
SLGN icon
77
Silgan Holdings
SLGN
$4.23B
$8.95M 0.38%
172,600
– –
ULTA icon
78
Ulta Beauty
ULTA
$22B
$8.92M 0.38%
19,015
-1,493
-7% -$644K
BMRN icon
79
BioMarin Pharmaceuticals
BMRN
$11.6B
$8.59M 0.37%
+83,000
New +$7.79M
ECL icon
80
Ecolab
ECL
$78.1B
$8.57M 0.37%
58,897
-44,903
-43% -$6.6M
WDAY icon
81
Workday
WDAY
$39.6B
$8.53M 0.37%
51,000
-2,000
-4% -$312K
ROL icon
82
Rollins
ROL
$18.3B
$8.44M 0.36%
231,049
– –
PLUS icon
83
ePlus
PLUS
$2.42B
$8.14M 0.35%
183,800
-2,800
-2% -$131K
SYK icon
84
Stryker
SYK
$125B
$7.91M 0.34%
32,371
– –
CROX icon
85
Crocs
CROX
$6.14B
$7.77M 0.33%
71,700
– –
WTS icon
86
Watts Water Technologies
WTS
$11.5B
$7.77M 0.33%
53,147
– –
SPLK
87
DELISTED
Splunk Inc
SPLK
$7.66M 0.33%
89,000
+5,000
+6% +$404K
LULU icon
88
lululemon athletica
LULU
$13.5B
$7.37M 0.32%
23,000
-2,000
-8% -$658K
JPM icon
89
JPMorgan Chase
JPM
$935B
$7.24M 0.31%
54,025
-20,975
-28% -$2.66M
FFIN icon
90
First Financial Bankshares
FFIN
$5.04B
$7.1M 0.3%
206,496
– –
ENSG icon
91
The Ensign Group
ENSG
$10.4B
$6.75M 0.29%
71,300
– –
OKTA icon
92
Okta
OKTA
$24.7B
$6.7M 0.29%
98,000
-18,000
-16% -$1.03M
BX icon
93
Blackstone
BX
$102B
$6.68M 0.29%
90,000
-15,000
-14% -$1.3M
WK icon
94
Workiva
WK
$3.36B
$6.42M 0.28%
76,400
– –
DIS icon
95
Walt Disney
DIS
$167B
$6.34M 0.27%
73,000
-32,000
-30% -$3.06M
USPH icon
96
US Physical Therapy
USPH
$1.2B
$6.3M 0.27%
77,800
– –
TSLA icon
97
Tesla
TSLA
$1.23T
$6.12M 0.26%
49,716
-10
-0% -$1.89K
SF
98
Stifel
SF
$12.6B
$6.1M 0.26%
156,633
– –
MSCI icon
99
MSCI
MSCI
$41.6B
$6.05M 0.26%
+13,000
New +$6.05M
FCN icon
100
FTI Consulting
FCN
$4.4B
$5.75M 0.25%
36,200
– –
2 3
4
5 6

Similar funds

LFG
Larson Financial Group St Louis, Missouri $3.13B AUM 22.88% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.12B AUM 12.93% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CCI
Cevian Capital II St. Helier, Jersey $3.12B AUM 25.62% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
TCG
Tremblant Capital Group West Palm Beach, Florida $3.11B AUM 18.12% 1-Year Est. Return

EULAV Asset Management's Q4 2022 Portfolio in Review

As of Q4 2022, EULAV Asset Management held 203 positions worth $2.33B, up 3.1% from $2.26B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

EULAV Asset Management withdrew a net $89.7M in Q4 2022, closing 11 positions and reducing 65 holdings. Its most notable exit was Arch Capital, an estimated $24.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Industrials and Financials.

Against the trend, EULAV Asset Management opened a new position in BioMarin Pharmaceuticals worth $8.59M.

  • EULAV Asset Management's largest Q4 2022 buy was BioMarin Pharmaceuticals: 83,000 shares worth $8.59M.
  • EULAV Asset Management added most to Idexx Laboratories in Q4 2022, an estimated $12.8M increase.
  • EULAV Asset Management's biggest Q4 2022 reduction was Danaher, cutting an estimated $29.3M.
  • EULAV Asset Management fully exited Arch Capital in Q4 2022, selling an estimated $24.2M.
  • EULAV Asset Management's ten largest holdings make up 23% of its $2.33B portfolio in Q4 2022.
  • EULAV Asset Management opened 5 new positions and closed 11 in Q4 2022.
  • EULAV Asset Management's portfolio value rose 3.1% quarter-over-quarter to $2.33B.

Based on EULAV Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.